Pseudoverticin, a novel benzoquinone-derived ansamycin antibiotic obtained as new cell cycle inhibitor from Streptomyces pseudoverticillus YN17707

Tetrahedron Letters

Volumn 48, Issue 28, 2007, Pages 4839-4843

  Cui, Cheng Bin ^a   Han, Bing ^b   Cai, Bing ^b   Wang, Hao ^a,b  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b Beijing Institute of Biomedicine   (China)

Author keywords

Ansamycin antibiotic; Cell cycle inhibitor; Geldanamycin; Pseudoverticin; Streptomyces pseudoverticillus; Structure

Indexed keywords

ANSAMYCIN DERIVATIVE; ANTIBIOTIC AGENT; BENZOQUINONE DERIVATIVE; GELDANAMYCIN; PSEUDOVERTICIN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; DRUG ISOLATION; FERMENTATION; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEPARATION TECHNIQUE; STREPTOMYCES; STREPTOMYCES PSEUDOVERTICILLUS; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROSCOPY;

STREPTOMYCES;

EID: 34250014714     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.05.052     Document Type: Article

References (75)

1. DeBoer C., Meulman P.A., Wnuk R.J., and Peterson D.H. J. Antibiot. 23 (1970) 442-447
2. Sasaki K., Rinehart Jr. K.L., Slomp G., Grostic M.F., and Olson E.C. J. Am. Chem. Soc. 92 (1970) 7591-7593
3. Andrus M.B., Meredith E.L., Simmons B.L., Sekhar B.B.V.S., and Hicken E.J. Org. Lett. 4 (2002) 3549-3552
4. Andrus M.B., Meredith E.L., Hiken E.J., Simmons B.L., Glancey R.R., and Ma W. J. Org. Chem. 68 (2003) 8162-8169
5. Ōmura S., Iwai Y., Takahashi Y., Sadakane N., Nakagawa A., Ōiwa H., Hasegawa Y., and Ikai T. J. Antibiot. 32 (1979) 255-261
6. Ōmura S., Nakagawa A., and Sadakane N. Tetrahedron Lett. (1979) 4323-4326
7. Furusaki A., Matsumoto T., Nakagawa A., and Ōmura S. J. Antibiot. 33 (1980) 781-782
8. Iwai Y., Nakagawa A., Sadakane N., Ōmura S., Ōiwa H., Matsumoto S., Takahashi M., Ikai T., and Ochiai Y. J. Antibiot. 33 (1980) 1114-1119
9. Shibata K., Satsumabayashi S., Nakagawa A., and Ōmura S. J. Antibiot. 39 (1986) 1630-1633
10. Shibata K., Satsumabayashi S., Sano H., Komiyama K., Nakagawa A., and Ōmura S. J. Antibiot. 39 (1986) 415-423
11. Tanida S., Hasegawa T., and Higashide E. J. Antibiot. 33 (1980) 199-204
12. Muroi M., Izawa M., Kosai Y., and Asai M. J. Antibiot. 33 (1980) 205-212
13. Muroi M., Haibara K., Asai M., Kamiya K., and Kishi T. Tetrahedron 37 (1981) 1123-1130
14. Damberg M., Russ P., and Zeeck A. Tetrahedron Lett. 23 (1982) 59-62
15. Lazar G., Zähner H., Damberg M., and Zeeck A. J. Antibiot. 36 (1983) 187-189
16. Sugita M., Furihata K., Seto H., Ōtake N., and Sasaki T. Agric. Biol. Chem. 46 (1982) 1111-1113
17. Sugita M., Natori Y., Sasaki T., Furihata K., Shimazu A., Seto H., and Ōtake N. J. Antibiot. 35 (1982) 1460-1466
18. Sugita M., Sasaki T., Furihata K., Seto H., and Ōtake N. J. Antibiot. 35 (1982) 1467-1474
19. Stead P., Latif S., Blackaby A.P., Sidebottom P.J., Deakin A., Taylor N.L., Life P., Spaull J., Burrell F., Jones R., Lewis J., Davidson I., and Mander T. J. Antibiot. 53 (2000) 657-663
20. Takatsu T., Ohtsuki M., Muramatsu A., Enokita R., and Kurakata S. J. Antibiot. 53 (2000) 1310-1312
21. Sasaki K., Yasuda H., and Onodera K. J. Antibiot. 32 (1979) 849-851
22. Schnur R.C., and Corman M.L. J. Org. Chem. 59 (1994) 2581-2584
23. Schnur R.C., Corman M.L., Gallaschun R.J., Cooper B.A., Dee M.F., Doty J.L., Muzzi M.L., Moyer J.D., DiOric C.I., Barbacci E.G., Miller P.E., O'Brien A.T., Morin M.J., Foster B.A., Pollack V.A., Savage D.M., Sloan D.E., Pustilnik L.R., and Moyer M.P. J. Med. Chem. 38 (1995) 3806-3812
24. Whitesell L., Mimnaugh E.G., Costa B.D., Myers C.E., and Neckers L.M. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8324-8328
25. Zhao C., and Wang E. Cell. Signalling 16 (2004) 313-321
26. Yamaki H., Nakajima M., Seimiya H., Saya H., Sugita M., and Tsuruo T. J. Antibiot. 48 (1995) 1021-1026
27. Villa R., Folini M., Porta C.D., Valentini A., Pennati M., Daidone M.G., and Zaffaroni N. Carcinogenesis 24 (2003) 851-859
28. Vasilevskaya I.A., Rakitina T.V., and O'Dwyer P.J. Cancer Res. 63 (2003) 3241-3246
29. Gossett D.R., Bradley M.S., Jin X., and Lin J. Gynecol. Oncol. 96 (2005) 381-388
30. Vasilevskaya I.A., and O'Dwyer P.J. Biochem. Pharmacol. 70 (2005) 580-589
31. Eiseman J.L., Lan J., Lagattuta T.F., Hamburger D.R., Joseph E., Covey J.M., and Egorin M.J. Cancer Chemother. Pharmacol. 55 (2005) 21-32
32. Liao Z., Zhang S., and Zhen Y. Acta Pharmaceutica Sinica 36 (2001) 569-575
33. Machida H., Matsumoto Y., Shirai M., and Kubota N. Int. J. Radiat. Biol. 79 (2003) 973-980
34. Kaarniranta K., Ryhänen T., Sironen R.K., Suuronen T., Elo M.A., Karjalainen H.M., Lammi M.J., Teräsvirta M., Uusitalo H., and Salminen A. Mol. Brain Res. 137 (2005) 126-131
35. Bedin M., Gaben A.-M., Saucier C., and Mester J. Int. J. Cancer 109 (2004) 643-652
36. Nomura M., Nomura N., Newcomb E.W., Lukyanov Y., Tamasdan C., and Zagzag D. J. Cell. Physiol. 201 (2004) 374-384
37. López-Maderuelo M.D., Fernández-Renart M., Moratilla C., and Renart J. FEBS Lett. 490 (2001) 23-27
38. Elo M.A., Kaarniranta K., Helminen H.J., and Lammi M.J. Biochim. Biophys. Acta 1743 (2005) 115-119
39. Barzilay E.B., Ben-Califa N., Shahar M., Kashman Y., and Neumann D. Biochem. Biophys. Res. Commun. 330 (2005) 561-564
40. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., and Pavletich N.P. Cell 89 (1997) 239-250
41. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. J. Med. Chem. 42 (1999) 260-266
42. Lee Y.-S., Marcu M.G., and Neckers L. Chem. Biol. 11 (2004) 991-998
43. Jez J.M., Chen J.C.-H., Rastelli G., Stroud R.M., and Santi D.V. Chem. Biol. 10 (2003) 361-368
44. Chiosis G., Rosen N., and Sepp-Lorenzino L. Bioorg. Med. Chem. Lett. 11 (2001) 909-913
45. Kasuya Y., Lu Z.-R., Kopečková P., and Kopeček J. Bioorg. Med. Chem. Lett. 11 (2001) 2089-2091
46. Hargreaves R., David C.L., Whitesell L., and Skibo E.B. Bioorg. Med. Chem. Lett. 13 (2003) 3075-3078
47. Lemarchand A., and Bach T. Tetrahedron 60 (2004) 9659-9673
48. Tian Z.-Q., Liu Y., Zhang D., Wang Z., Dong S.D., Carreras C.W., Zhou Y., Rastelli G., Santi D.V., and Myles D.C. Bioorg. Med. Chem. 12 (2004) 5317-5329
49. Brazidec J.-Y.L., Kamal A., Busch D., Thao L., Zhang L., Timony G., Grecko R., Trent K., Lough R., Salazar T., Khan S., Burrows F., and Boehm M.F. J. Med. Chem. 47 (2004) 3865-3873
50. Shen Y., Xie Q., Norberg M., Sausville E., Woude G.V., and Wenkert D. Bioorg. Med. Chem. 13 (2005) 4960-4971
51. Hu Z., Liu Y., Tian Z.-Q., Ma W., Starks C.M., Regentin R., Licari P., Myles D.C., and Hutchinson C.R. J. Antibiot. 57 (2004) 421-428
52. Patel K., Piagentini M., Rascher A., Tian Z.-Q., Buchanan G.O., Regentin R., Hu Z., Hutchinson C.R., and McDaniel R. Chem. Biol. 11 (2004) 1625-1633
53. Johnson R.D., Haber A., and Rinehart Jr. K.L. J. Am. Chem. Soc. 96 (1974) 3316-3317
54. Haber A., Johnson R.D., and Rinehart Jr. K.L. J. Am. Chem. Soc. 99 (1977) 3541-3544
55. Allen I.W., and Ritchie D.A. Mol. Gen. Genet. 243 (1994) 593-599
56. Rascher A., Hu Z., Viswanathan N., Schirmer A., Reid R., Nierman W.C., Lewis M., and Hutchinson C.R. FEMS Microbiol. Lett. 218 (2003) 223-230
57. Neckers L. Trends Mol. Med. 8 (2002) S55-S61
58. Carreras C.W., Schirmer A., Zhong Z., and Santi D.V. Anal. Biochem. 317 (2003) 40-46
59. Sreedhar A.S., Söti C., and Csermely P. Biochim. Biophys. Acta 1697 (2004) 233-241
60. Sreedhar A.S., and Csermely P. Pharmacol. Ther. 101 (2004) 227-257
61. Kamal A., Boehm M.F., and Burrows F.J. Trends Mol. Med. 10 (2004) 283-290
62. Sreedhar A.S., Nardai G., and Csermely P. Immunol. Lett. 92 (2004) 157-161
63. Echeverria P.C., Matrajt M., Harb O.S., Zappia M.P., Costas M.A., Roos D.S., Dubremetz J.F., and Angel S.O. J. Mol. Biol. 350 (2005) 723-734
64. Wang H., Cui C.-B., Han B., Liu Z.-H., Song Y.-X., and Zhou P.-J. Chin. J. Antibiot. 26 (2001) 19-24
65. Cui C.-B., Wang H., Han B., Cai B., Luo A.-Q., Song Y.-X., and Zhou P.-J. Chin. J. Antibiot. 26 (2001) 165-170
66. Cui C.-B., Wang H., Han B., and Song Y.-X. Chin. J. Med. Chem. 11 (2001) 25-31
67. Han B., Cui C.-B., Cai B., and Yao X.-S. Chin. J. Med. Chem. 14 (2004) 370-372
68. Han B., Cui C.-B., Cai B., Ji X.-F., and Yao X.-S. Chin. Chem. Lett. 16 (2005) 471-474
69. Liu W., Gu Q., Zhu W., Cui C., Fan G., Zhu T., Liu H., and Fang Y. Tetrahedron Lett. 46 (2005) 4993-4996
70. Han X.-X., Cui C.-B., Gu Q.-Q., Zhu W.-M., Liu H.-B., Gu J.-Y., and Osada H. Tetrahedron Lett. 46 (2005) 6137-6140
71. 3OD (1:1): 168.4 s (C-1), 134.5 s (c-2), 127.4 d (C-3), 126.1 d (C-4), 136.4 d (C-5), 81.3 d (C-6), 81.4 d (C-7), 133.1 s (C-8), 132.7 d (C-9), 32.2 d (C-10), 72.6 d (C-11), 80.9 d (C-12), 34.2 t (C-13), 27.9 d (C-14), 32.3 t (C-15), 127.9 s (C-16), 156.9 s (C-17), 184.5 s (C-18), 111.5 d (C-19), 138.2 s (C-20), 184.2 s (C-21), 12.3 q (C-23), 57.1 q (C-24), 156.6 s (C-25), 12.5 q (C-27), 12.1 q (C-28), 56.5 q (C-29), 22.7 q (C-30), 61.4 q (C-31).
72. 13C NMR Spectroscopy: High-resolution methods and applications in organic chemistry and biochemistry. 3rd completely rev. ed. (1987), VCH, Weinheim, NY p 115-116 and p 183-191)
73. The biosynthetic pathway of 2 has been well investigated (see Refs. 15a,b) and the cloning of gene cluster for geldannamycin production has also been accomplished (see Refs. 15c,d) to obtain novel geldanamycin derivatives with the same absolute stereochemistry of the ansa ring by generating them through genetic engineering on the gene cluster for geldannamycin production (see Ref. 14).
74. Mann J., Davidson R.S., Hobbs J.B., Banthorpe D.V., and Harborne J.B. Natural Products: Their Chemistry and Biological Significance (1996), Addison Wesley Longman Limited, Essex, England pp 1-20 and pp 239-287
75. Kobayashi M., Frenzel T., Lee J.P., Zenk M.H., and Floss H.G. J. Am. Chem. Soc. 109 (1987) 6184-6185 and references cited therein